Mark Reddish, Vice President Development
https://markertherapeutics.com/wp-content/uploads/2014/12/White-Paper-Immunotherapy-in-the-Age-of-Vaccinomics-Mark-Reddish-TapImmune-Inc.pdf

Category: Science Publications